WebDec 31, 2024 · Fulcrum UCITS SICAV Fulcrum Ucits Sicav - Fulcrum Income Fund Class F (GBP) Dist LU2236194879 F0007-0101 Thursday, 19 November 2024 Thursday, 31 December 2024 GBP 0.0000 Wednesday, 30 June 2024 Yes 0.0077 Tuesday, 01 December 2024 0.0852 Monday, 04 January 2024 Fulcrum UCITS SICAV Fulcrum … Web10. UnitedHealth Group Inc Healthcare Services 2.39% 11. United States Treasury 4.00% 15-Nov-2052 Fixed Income 2.33% 12. Berkshire Hathaway Inc Cl A Insurance 2.24% 13. Live Nation Entertainment Inc Leisure 2.16% 14. Microsoft Corp Information Technology 2.13% 15. Meta Platforms Inc Cl A Information Technology 2.04%
Fulcrum Income Fund Fund Fact Sheet Citywire
WebDec 23, 2024 · FULCRUM CLIMATE CHANGE FUND, FULCRUM THEMATIC EQUITY MARKET NEUTRAL FUND and FULCRUM INCOME FUND is determined on each Business Day (the “Valuation Day”). If any such Valuation Day falls on a day which is not a Business Day, the Net Asset Value per Share of the Sub-Fund will be determined on the … WebTM Fulcrum Income Fund F Acc GBP Share Class (GB00BD5GC076) F Inc GBP Share Class (GB00BF8F7115) 31 January 2024 For professional investors only. PORTFOLIO & RISK Individual Risk Exposure by Strategy Directional 4.9% Macro Equities - Europe ex-UK 1.7% Macro Equities - North America 1.2% Real Assets 0.5% Credit 0.4% Fixed Income … fm inhibition\\u0027s
Morningstar Financial Research, Analysis, Data and News
WebApr 26, 2024 · Global multi-asset manager Fulcrum Asset Management has appointed head of equities Fawaz Chaudhry and lead portfolio manager Stephen Crewe as partners at the firm. Head of equities Chaudhry is lead portfolio manager of the Fulcrum Thematic Equity Market Neutral Fund and Fulcrum Climate Change Fund. WebTM Fulcrum Income Fund C GBP Inc: Macro Trading GBP: The Fund aims to generate an annual income of 4.5% above the Bank of England Base Rate (before tax payable by the Fund) regardless of market ... WebAug 10, 2024 · Fulcrum Therapeutics, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $4.38 million for the quarter ended June 2024, surpassing the Zacks Consensus... fm inhibition\u0027s